GTMRx Institute

What GTMRx Institute does

GTMRx Institute (Get The Medications Right) is a Washington, D.C.-headquartered 501(c)(4) non-profit healthcare coalition founded in April 2019 by Katherine H. Capps and Paul Grundy, MD. The institute operates as a multi-stakeholder consensus organization bringing together 1,800+ members from 620+ organizations across physicians, clinical pharmacists, payers, employers, health IT companies, diagnostic laboratories, consumer advocacy groups, and health systems to advance Comprehensive Medication Management (CMM) — a systematic, team-based approach to ensuring each patient's medications are individually appropriate, effective, safe, and taken as intended. Leadership rests with co-founder/Executive Director Katherine Capps and President Paul Grundy, MD (former IBM Healthcare chief medical officer, founding president of the PCPCC, and the figure widely credited as the \"godfather\" of the patient-centered medical home), with a Board that includes senior executives of ASHP, ACCP, America's Physician Groups, the Veterans Health Administration, and Tempus.

GTMRx's core intellectual outputs are consensus documents and implementation tools rather than commercial software: (1) the GTMRx 10-Step CMM Process, a systematic reiterative framework for medication optimization; (2) the CMM Practice Management Tool, co-developed with the University of Minnesota College of Pharmacy and the UNC Eshelman School of Pharmacy to assess CMM practice across five domains — Organizational Support, Care Team Engagement, Care Delivery Processes, Program Evaluation, and Quality Assurance; (3) the National Registry of Comprehensive Medication Management Practices, a benchmarking registry tracking CMM practice maturity, staffing models, and outcomes across healthcare settings; and (4) policy frameworks including the Blueprint for Change (July 2020), the Consensus Guidance on Payment and Policy Recommendations (May 2022), the Employer Toolkit, and the Consumer Toolkit. The institute operates four standing workgroups — Payment and Policy Solutions, Practice & Care Delivery Transformation, Precision Medicine Enablement via Advanced Diagnostics, and HIT and AI to Support Optimized Medication Use — plus taskforces on vaccine confidence, employer advisement, and pharmacogenomics. Resources are distributed through gtmr.org, a weekly email news brief, the GTMRx Learning Network webinar series, the Voices of Change podcast, and policy events co-hosted with the Bipartisan Policy Center.

Revenue is generated through tiered sponsorship programs rather than product sales. The freemium model begins with free \"Signing Members\" (individuals and organizations endorsing GTMRx's belief statements) and escalates to paid \"Executive Members\" (annual organizational sponsors), Gold/Silver/Bronze \"Strategic Partners\" (AbbVie, Genentech, LabCorp, OneOme and others at Gold; Cleveland Clinic and Cureatr among Silver), and five \"Founding Funders\" on three-year board-level commitments. A separate 501(c)(3) GTMRx Foundation accepts tax-deductible donations to support free member resources and educational outreach. Specific pricing is not publicly disclosed. GTMRx pursues policy advocacy directly targeting CMS, Congress, the Office of Personnel Management, and state legislatures, leveraging its Bipartisan Policy Center partnership and embedded credibility across pharmacy (ASHP, 60,000 members), clinical pharmacy (ACCP), federal health systems (Veterans Health Administration), and physician-group leadership (America's Physician Groups) to position CMM as a reimbursable standard of care.

Name

GTMRx Institute

Legal name

GTMRx Institute

Website

https://gtmr.org

Company type

Private

Founded year

2019

Operating status

Operating

Headcount range

1–10 employees

Short description

GTMRx Institute is a Washington, D.C.-based 501(c)(4) healthcare coalition advancing Comprehensive Medication Management (CMM) through multi-stakeholder consensus-building, practice transformation tools, and policy advocacy targeting physicians, pharmacists, payers, employers, and health systems.

Ownership category

akta.pro rank

Product category

Healthcare Coalition Advocacy

NAICS

Business Associations (813910), Other Scientific and Technical Consulting Services (54169)

SIC

Services-Management Consulting Services (8742)

akta.pro primary industry

Pharmacogenomics (PGx) Decision Support (HLAAANAB)

akta.pro secondary industries

Training & Competency Programs for GxP Compliance (HLAGAKAM), Quality Management Systems (QMS) & GxP Documentation (HLAGAKAD)

Keywords

• Comprehensive medication management
• Healthcare coalition advocacy
• Medication optimization policy
• Pharmacy practice transformation
• Medication safety education

Headquarters

HQ city

Vienna

HQ country

United States

HQ region

North America

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Marketing or Sales, Others

Revenue model

1. Signing Membership (Free): Free membership for individuals and organizations that agree with GTMRx belief statements and want to support the mission. Signing Members gain access to webinars, news briefs, white papers, issue briefs, workgroup participation, and policy updates.
2. Executive Membership (Annual Sponsorship): Annual organizational sponsorship fee for entities seeking active leadership roles — leading taskforces, being credited in meetings and public outreach, and publicly aligned with GTMRx work. Includes participation in GTMRx Learning Network.
3. Founding Funder Program (3-Year Commitment): Three-year financial and time commitment from five founding organizations, including active leadership on the Board of Directors, influence over campaigns, briefings, participation in outreach, and leadership in developing the Blueprint for Change.
4. Event and Program Sponsorships: Organizations may sponsor specific programs, white papers, webinars, learning series, or events in support of GTMRx's mission and vision.
5. GTMRx Foundation Donations (501(c)(3)): Tax-deductible charitable donations to the GTMRx Foundation (separate 501(c)(3) entity) supporting educational outreach, awareness building, and information dissemination. Donations fund practice and policy transformations and free member resources.

Pricing tiers

Go-to-market motion1 record

Distribution channels5 records

Marketing channels8 records

Core offering

GTMRx Institute is a multi-stakeholder healthcare coalition that advances the adoption of Comprehensive Medication Management (CMM) as the standard of care. It operates workgroups, taskforces, webinars, and policy advocacy to align physicians, pharmacists, payers, employers, health IT companies, and consumer groups around CMM implementation. The institute monetizes through tiered organizational memberships, multi-year founding funder commitments, event sponsorships, and donations to its affiliated 501(c)(3) GTMRx Foundation.

Product overview

GTMRx Institute operates as a catalyst for change in healthcare, centered on Comprehensive Medication Management (CMM) — a systematic, team-based approach ensuring patient medications are appropriate, effective, safe, and able to be taken as intended. The organization provides a suite of educational resources, tools, and programs including the CMM Practice Management Tool for practitioners, the National Registry of CMM Practices for benchmarking, the GTMRx Learning Network (webinars, podcasts, issue briefs), employer and consumer toolkits, and consensus guidance documents. Multiple workgroups and taskforces address payment/policy solutions, practice transformation, precision medicine enablement, and health IT. The organization does not offer a traditional SaaS product but rather serves as a multi-stakeholder institute focused on advocacy, education, and practice transformation.

Differentiator

Problem solved

Functional benefit

Brands

• GTMRx Learning Network: Educational platform providing webinars, issue briefs, news briefs, podcasts (Voices of Change series), and networking opportunities for members.
• GTMRx National Registry of Comprehensive Medication Management Practices
• Blueprint for Change

Products and services

• Comprehensive Medication Management (CMM) Program A systematic, team-based standard of care in which clinical pharmacists collaborate with physicians to individually assess each patient's medications (prescription, nonprescription, alternative, traditional, vitamins, nutritional supplements) for appropriateness, effectiveness, safety, and ability to be taken as intended. Targeted at health systems, primary care practices, and integrated delivery networks seeking to reduce medication-related harm.
• CMM Practice Management Tool Self-assessment tool for individual practitioners and practice sites to identify and prioritize areas of CMM practice improvement, organized around five core components: Organizational Support, Care Team Engagement, Care Delivery Processes, CMM Program Evaluation, and Ensuring Consistent and Quality Care. Developed with the University of Minnesota College of Pharmacy and UNC Eshelman School of Pharmacy.
• GTMRx Learning Network Educational platform providing webinars, issue briefs, news briefs, podcasts (Voices of Change series), videos, and consensus documents for healthcare professionals, payers, employers, and policy makers focused on CMM practice transformation, evidence, and payment/policy reform.
• National Registry of Comprehensive Medication Management Practices A national registry documenting CMM practice maturity levels, staffing models, quality measures, and implementation challenges across diverse healthcare settings to enable benchmarking and broader adoption of CMM.
• GTMRx Blueprint for Change Consensus document outlining areas of focus and activities designed to inform payment and policy solutions for practice transformation in comprehensive medication management, used by healthcare providers, payers, employers, and policy makers.
• Executive Membership Sponsorship Annual organizational sponsorship offering active leadership roles, including leading taskforces, being credited in meetings and public outreach, and participation in the GTMRx Learning Network. Targeted at healthcare organizations, payers, employers, and health systems seeking leadership visibility in CMM advocacy.
• Founding Funder Program Three-year financial and time commitment from a small group of founding organizations, including active leadership on the Board of Directors, influence over campaigns and briefings, participation in outreach, and leadership in developing the Blueprint for Change.
• Employer Toolkit Resources for employers and health plan sponsors to understand and implement CMM, including FAQs, infographics on drug spend, guidance on using pharmacogenomics, contracting guidance, and evidence documents.
• Consumer Toolkit Resources to inform and educate consumers about comprehensive medication management, including consumer survey results, patient journey infographic, explainer videos, caregiver videos, podcasts, and FAQs.

Quantifiable outcome

• $528 billion annual cost of non-optimized medication use in the U.S., equivalent to 16% of total healthcare spending (Watanabe et al., Annals of Pharmacotherapy, 2018)
• +4 more outcomes

Named customers10 records

Segments4 records

Ideal customer profiles5 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

26 partnerships are on record, tiered gold, silver, bronze, executive member and core.

• Teachers' Retirement System of Kentucky (TRS)goldStrategic or Co-development PartnerGold Strategic Partner. TRS, a public pension plan for Kentucky educators, participates in GTMRx leadership, presents on CMM with pharmacogenomics for retirees, and co-develops employer-focused resources on medication optimization through the Employer Toolkit Taskforce.
• AbbVie Inc.goldStrategic or Co-development PartnerGold Strategic Partner. AbbVie supports GTMRx's mission to advance comprehensive medication management and medication optimization as part of the institute's multi-stakeholder coalition.
• GenentechgoldStrategic or Co-development PartnerGold Strategic Partner. Genentech, a biotechnology company, participates as a Gold-level strategic partner supporting GTMRx's practice transformation, evidence, and policy initiatives.
• LabCorpgoldStrategic or Co-development PartnerGold Strategic Partner. LabCorp, a global life sciences company and diagnostic lab, supports GTMRx's precision medicine enablement through advanced diagnostics workgroup and pharmacogenomics initiatives.
• Kimber Boothe Group, LLCgoldStrategic or Co-development PartnerGold Strategic Partner. The Kimber Boothe Group, a healthcare consulting firm, supports GTMRx as a strategic partner in advancing CMM practice and policy transformation.
• American Association of Colleges of Pharmacy (AACP)goldStrategic or Co-development PartnerGold Strategic Partner. AACP, representing pharmacy colleges and schools, supports GTMRx through academic leadership engagement, pharmacy workforce education, and CMM curriculum development.
• OneOmegoldStrategic or Co-development PartnerGold Strategic Partner. OneOme, a pharmacogenomics testing company, supports GTMRx's precision medicine enablement workgroup and participates in developing PGx integration guidance for CMM practice.
• Breast Cancer IndexgoldStrategic or Co-development PartnerGold Strategic Partner. Breast Cancer Index, a molecular diagnostics company, participates in GTMRx's precision medicine and diagnostics-focused initiatives.
• National Alliance Health (NAEHP/NAEHN)goldStrategic or Co-development PartnerGold Strategic Partner. National Alliance Health is a coalition of employer-based health coalitions and health purchasing alliances that supports GTMRx's employer-focused initiatives and value-based care advocacy.
• The Journal of Precision MedicinegoldStrategic or Co-development PartnerGold Strategic Partner. The Journal of Precision Medicine supports GTMRx's precision medicine education and publishes GTMRx-affiliated research and white papers on pharmacogenomics and CMM integration.
• Cleveland ClinicsilverStrategic or Co-development PartnerSilver Strategic Partner. Cleveland Clinic, a leading integrated health system, participates in GTMRx workgroups and has contributed a CMM use case demonstrating pharmacist integration in a large health system setting.
• CureatrsilverStrategic or Co-development PartnerSilver Strategic Partner. Cureatr, a medication management technology company, supports GTMRx's health IT and medication optimization initiatives.
• GenomindsilverStrategic or Co-development PartnerSilver Strategic Partner. Genomind, a pharmacogenomics testing company, participates in GTMRx's Precision Medicine Enablement via Advanced Diagnostics Workgroup and develops PGx-related resources.
• PhactMIsilverStrategic or Co-development PartnerSilver Strategic Partner. PhactMI is a network of pharmacist-led healthcare companies supporting GTMRx's clinical pharmacy integration and CMM practice transformation goals.
• Clinical Specialists in Rheumatology (CSRO)bronzeStrategic or Co-development PartnerBronze Strategic Partner. CSRO represents rheumatology specialists and supports GTMRx's mission from a specialty care and medication optimization perspective.
• Avera HealthbronzeStrategic or Co-development PartnerBronze Strategic Partner. Avera Health, an integrated rural health system, has provided a GTMRx use case on CMM in long-term care settings and participates in practice transformation workgroups.
• Empirx HealthbronzeStrategic or Co-development PartnerBronze Strategic Partner. Empirx Health supports GTMRx's medication management and CMM practice transformation initiatives.
• Accessible Medicines (AAM)bronzeStrategic or Co-development PartnerBronze Strategic Partner. Accessible Medicines (formerly Association for Accessible Medicines) supports GTMRx's medication access and affordability policy initiatives.
• College of Psychiatric and Neurologic Pharmacists (CPNP)bronzeStrategic or Co-development PartnerBronze Strategic Partner. CPNP supports GTMRx through behavioral health and neurologic medication management expertise, contributing to the Precision Medicine Enablement and Practice Transformation workgroups.
• Primary Care Collaborative (PCC)bronzeStrategic or Co-development PartnerBronze Strategic Partner. PCC, led by Ann Greiner, collaborates with GTMRx on joint webinars and advocacy for team-based care models integrating clinical pharmacists.
• California Chronic Care Coalitionexecutive memberStrategic or Co-development PartnerExecutive Member. The California Chronic Care Coalition (CCCC), led by Liz Helms, is a consumer/patient advocacy coalition representing chronic disease patients, actively participating in GTMRx workgroups and policy advocacy.
• Kaiser Permanente (Maryland/Virginia/DC)executive memberStrategic or Co-development PartnerExecutive Member. Kaiser Permanente participates as an executive member, contributing to GTMRx leadership, workgroups, and providing clinical pharmacy integration perspectives from a large integrated delivery system.
• Tria Healthexecutive memberStrategic or Co-development PartnerExecutive Member and newest Strategic Partner (as of January/February 2022). Tria Health, led by CEO Jessica Lea, provides medication management services and co-presents on employer-focused CMM value.
• Tabula Rasa HealthCareexecutive memberStrategic or Co-development PartnerExecutive Member. Tabula Rasa HealthCare (now CareKinesis) supports GTMRx through its medication risk stratification technology and participates in health IT workgroups. Brian Litten, Chief Strategic Growth Officer, presents on GTMRx webinars.
• Veterans Health Administration (VA)executive memberStrategic or Co-development PartnerExecutive Member. The VA participates as an executive member, with VA clinical pharmacy leadership (Anthony Morreale, Julie Groppi, Heather Ourth, M. Shawn McFarland) driving GTMRx workgroups and contributing VA use cases on system-wide CMM implementation.
• Bipartisan Policy Center (BPC)coreStrategic or Co-development PartnerGTMRx co-hosts major policy events with BPC, including the February 2020 summit 'Get the Medications Right: Innovations in Team-Based Care' featuring leaders from VHA, Commonwealth Fund, and CMS. BPC provides policy legitimacy and multi-stakeholder convening power to GTMRx's advocacy mission.

Scale indicators6 records

Recent moves5 records

Expansion highlights4 records

Direct peers

• American Society of Health-System Pharmacists (ASHP): The largest association of pharmacy professionals in the United States, representing 60,000 pharmacists and pharmacy technicians. ASHP CEO Paul Abramowitz sits on GTMRx's Board of Directors, and ASHP is a Gold Strategic Partner — both organizations advocate for clinical pharmacist integration and team-based medication management.
• American College of Clinical Pharmacy (ACCP): A professional association advancing clinical pharmacy practice, research, and education. ACCP Executive Director Michael Maddux serves as Secretary/Treasurer on GTMRx's Board, and the two organizations collaborate on clinical pharmacist integration and CMM practice transformation — directly overlapping missions on medication optimization.
• OneOme: A pharmacogenomics testing company that is a Gold Strategic Partner of GTMRx. OneOme participates in GTMRx's Precision Medicine Enablement via Advanced Diagnostics Workgroup and co-develops PGx integration guidance for CMM — directly aligned in the PGx-enabled medication management niche.
• Primary Care Collaborative (PCC): A multi-stakeholder advocacy organization advancing team-based, patient-centered primary care. PCC is a Bronze Strategic Partner of GTMRx and the two organizations co-host webinars on integrating clinical pharmacists into primary care teams — directly comparable advocacy model and overlapping mission on team-based care.
• Academy of Managed Care Pharmacy (AMCP): A national association for pharmacists and other healthcare professionals who serve patients in managed care settings. AMCP's payer-focused perspective on medication therapy management overlaps directly with GTMRx's Payment and Policy Solutions Workgroup and employer/payer advocacy.
• America's Physician Groups (APG): A professional association representing physician groups practicing value-based care. APG CMO Susan Huang sits on GTMRx's Board, and the two organizations share a focus on integrated, value-based delivery models where clinical pharmacist integration and CMM adoption are critical to outcomes.
• Tabula Rasa HealthCare (CareKinesis): A medication risk stratification and pharmacy services company that is an Executive Member of GTMRx. Tabula Rasa's medication management technology and clinical pharmacist services overlap directly with GTMRx's CMM agenda, and the company's leadership participates in GTMRx health IT workgroups.
• National Alliance of Healthcare Purchaser Coalitions: A coalition of employer-based health coalitions and health purchasing alliances advancing value-based purchasing. As a Gold Strategic Partner of GTMRx, it co-develops employer-focused resources and amplifies the CMM agenda among self-insured employers — the same buyer segment GTMRx targets through its Employer Toolkit.

Broad incumbents

• American Pharmacists Association (APhA): The largest professional association of pharmacists in the US, advocating for the profession across practice settings. APhA's broader pharmacist-advocacy remit overlaps with GTMRx's CMM agenda, though APhA is a more generalist professional society rather than a CMM-specialized coalition.

Others

• Bipartisan Policy Center (BPC): A Washington, D.C.-based think tank that co-hosts major policy events with GTMRx (e.g., the February 2020 summit 'Get the Medications Right'). BPC is a Core policy ally rather than a direct competitor — it provides policy legitimacy and convening power that supports GTMRx's advocacy mission.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks6 records

Key highlights6 records

Customer concentration

• Xtwitter.com/GTMRxInstitute
• Facebookfacebook.com/GTMRxInstitute
• LinkedInlinkedin.com/company/35582280

Revenue estimate

Valuation estimate

Number of profiles

Profiles7 records

Subsidiaries1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about GTMRx Institute